Eliza Chakravarty to Abatacept
This is a "connection" page, showing publications Eliza Chakravarty has written about Abatacept.
Connection Strength
0.603
-
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis. Arthritis Res Ther. 2015 Jun 13; 17:159.
Score: 0.506
-
Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies. Curr Rheumatol Rep. 2011 Aug; 13(4):308-16.
Score: 0.097